David, Daniel
Dobrean, Anca
Păsărelu, Costina Ruxandra
Iftene, Felicia
Lupu, Viorel
Predescu, Elena
Döpfner, Manfred
Funding for this research was provided by:
National Council for Research (CEEX Contract no 78 / 2006)
Article History
Accepted: 14 September 2020
First Online: 2 October 2020
Compliance with Ethical Standards
:
: Daniel David is Director of Research and a Diplomate/Supervisor at the Albert Ellis Institute, SUA. Anca Dobrean received speaker fee from Eli Lilly. Viorel Lupu received speaker fees from Eli Lilly and Janssen Cilag. Elena Predescu received consulting and speaker fees from Eli Lilly, Janssen Cilag and research support from the Romanian Ministry of Education and Research. Manfred Döpfner received consulting income and research support from Lilly, Medice, Shire, Takeda, and Vifor and research support from the German Research Foundation, German Ministry of Education and Research, German Ministry of Health, and Innovation Fund. He received income as head, supervisor, and lecturer of the School of Child and Adolescent Cognitive Behaviour Therapy at the University Hospital Cologne and as consultant for Child Behaviour Therapy at the National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung). He also received royalties from treatment manuals, books and psychological tests published by Beltz, Elsevier, Enke, Guilford, Hogrefe, Huber, Kohlhammer, Schattauer, Springer, Wiley. Costina Ruxandra Păsărelu and Felicia Iftene declared no potential conflict of interests.
: All procedures performed involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from all individual participants included in the study.
: No animal studies were carried out by the authors for this article.